Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus plus low-dose tacrolimus in renal transplant recipients with BK virus infection
ChiCTR2200062308Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Jul 2022
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sirolimus and tacrolimus in BK polyomavirus infection, Kidney allograft status (RTx) and BK polyomavirus associated nephropathy (BKPyVAN) (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Urinary BK virus copy number. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
sirolimustacrolimus
03
Conditions
BK polyomavirus infectionKidney allograft status (RTx)BK polyomavirus associated nephropathy (BKPyVAN)
Beyond the preview
Go deeper on ChiCTR2200062308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062308.